| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BLINN MARK A | Director | 12500 TI BOULEVARD, DALLAS | /s/ Shannon Thompson, Attorney in Fact | 06 Feb 2026 | 0001129149 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXN | Common Stock | Options Exercise | $109,781 | +628 | +5.1% | $174.81 | 12,870 | 05 Feb 2026 | Direct | |
| transaction | TXN | Common Stock | Options Exercise | $94,014 | +540 | +4.2% | $174.10 | 13,410 | 05 Feb 2026 | Direct | |
| transaction | TXN | Common Stock | Options Exercise | $128,411 | +767 | +5.7% | $167.42 | 14,177 | 05 Feb 2026 | Direct | |
| transaction | TXN | Common Stock | Options Exercise | $119,138 | +637 | +4.5% | $187.03 | 14,814 | 05 Feb 2026 | Direct | |
| transaction | TXN | Common Stock | Sale | $696,647 | -3,144 | -21% | $221.58 | 11,670 | 05 Feb 2026 | Direct | F1 |
| holding | TXN | Common Stock | 3,046 | 05 Feb 2026 | By Trust | F2 | |||||
| holding | TXN | Common Stock | 6,000 | 05 Feb 2026 | By Trust | F3 | |||||
| holding | TXN | Common Stock | 6,000 | 05 Feb 2026 | By Trust | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TXN | NQ Stock Option (Right to Buy) | Options Exercise | $0 | -628 | -100% | $0.000000 | 0 | 05 Feb 2026 | Common Stock | 628 | $174.81 | Direct | F5 |
| transaction | TXN | NQ Stock Option (Right to Buy) | Options Exercise | $0 | -540 | -50% | $0.000000 | 540 | 05 Feb 2026 | Common Stock | 540 | $174.10 | Direct | F6 |
| transaction | TXN | NQ Stock Option (Right to Buy) | Options Exercise | $0 | -767 | -33% | $0.000000 | 1,533 | 05 Feb 2026 | Common Stock | 767 | $167.42 | Direct | F7 |
| transaction | TXN | NQ Stock Option (Right to Buy) | Options Exercise | $0 | -637 | -25% | $0.000000 | 1,914 | 05 Feb 2026 | Common Stock | 637 | $187.03 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $221.00 to $221.93. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| F2 | Shares held in Trust for the benefit of family member; reporting person shares investment control. Beneficial ownership by reporting person disclaimed. |
| F3 | Shares held in Trust for the benefit of family member of which reporting person is trustee. Beneficial ownership by reporting person disclaimed. |
| F4 | Shares held in Trust for the benefit of the reporting person. Reporting person is the sole trustee. |
| F5 | The option became exercisable in four equal annual installments beginning on January 27, 2023. |
| F6 | The option became exercisable in four equal annual installments beginning on January 26, 2024. |
| F7 | The option became exercisable in four equal annual installments beginning on January 25, 2025. |
| F8 | The option became exercisable in four equal annual installments beginning on January 27, 2026. |